Diferuloylmethane augments the cytotoxic effects of piplartine isolated from Piper chaba.
 

Posts


Write a Post
06-09-09 09:09 AM
Anonymous
Diferuloylmethane augments the cytotoxic effects of piplartine isolated from Piper chaba.
Reply
Related Articles

Diferuloylmethane augments the cytotoxic effects of piplartine isolated from Piper chaba.

Toxicol In Vitro. 2009 Jun 3;

Authors: Jyothi D, Vanathi P, Gowri PM, Rao VR, Rao JM, Sreedhar AS

Natural compound based anticancer drug discovery is gaining interest against a wide variety of tumors. E-piplartine (trans-piplartine), a natural compound isolated from Piper chaba roots is examined against rat histiocytoma (BC-8), mouse embryonal carcinoma (PCC4), mouse macrophages (P388D1 and J774), and human neuroblastoma (IMR-32) tumor cells. While Z-piplartine (cis-piplartine) failed to induce cytotoxicity (even at higher concentrations, 50 M), E-piplartine induced a dose-dependent cytotoxicity (2 muM- 24 muM) in different tumor cells. The combinatorial treatment of piplartine with diferuloylmethane (curcumin), an anti-inflammatory and anti-cancer agent, significantly enhanced the piplartine induced cytotoxicity in tumor cells. Diferuloylmethane itself is not cytotoxic at 15 muM concentration; however, potentiated the piplartine induced cytotoxicity. The tumor cell killing with piplartine is preceded by G1 cell cycle arrest, and surpassed diferuloylmethane induced G2/M arrest when used in combination. In PCC4 cells, piplartine inhibited the cell cycle progression by inactivating cdk2 and destabilizing cyclin D1, whereas diferuloylmethane combination inhibited the ERK1/2 and Raf-1 signaling in addition to the inhibition of cell cycle progression. The over expression of heat shock protein 70, Hsp70 in rat histiocytic tumor cells interfered with piplartine induced cytotoxicity, hence, a cross talk between stress response and anticancer agents is presented. Our data demonstrates the biological and medicinal importance of piplartine isolated from the roots of Piper chaba, and indicates that E-piplartine may be a promising candidate to use in combinatorial treatments to combat cancer.

PMID: 19501152 [PubMed - as supplied by publisher]